TGFBR2 and breast carcinoma: Therefore, the observation that SOX4 and SMARCA4 mediate PI3K activity through TGFBR2 expression identifies a novel and direct role for TGFBR2 in activating noncanonical PI3K signaling in basal-like breast cancer.